Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma. Kim K, Shah R, Ayers A, Ahmed S, et al. Br J Haematol 2026 Jan 11. doi: 10.1111/bjh.70325.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim K, Shah R, Ayers A, Ahmed S, et al. Clinical trial access after CAR T-cell therapy failure in relapsed/refractory large B-cell lymphoma. Br J Haematol 2026 Jan 11. doi: 10.1111/bjh.70325.
PMID: 41521615